Who ever said, “vino veritas” (in wine, there is truth), hasn’t written enough. I say, “in writing veritas.” MarketWatch asked me to write an article about one’s investment strategy in the interest rate environment on the horizon. When I first sat down to write, I thought that I was a bit neutral on the direction of [...]
July 2, 2007 | Posted in Stock Analysis | Read More »
By Vitaliy Katsenelson I sang love serenades for Abbott Labs’ (ABT) stock for a long time. Call me materialistic, but my love for stocks is not ‘til death do us part,’ it is conditional of fundamentals staying intact and of valuation – it has to be undervalued. Abbott Labs’ fundamentals have improved over the last couple [...]
March 29, 2007 | Posted in Stock Analysis | Read More »
